Glytec and Parkview Health Join Forces to Enhance Diabetes Care
Glytec and Parkview Health Join Forces to Enhance Diabetes Care
Renewal of 10 facilities, new Emergency Department implementation, and hospital expansions strengthen Parkview's commitment to quality health care.
Glytec, a leading name in AI-powered diabetes and glycemic management, recently announced a significant expansion of its partnership with Parkview Health. This not-for-profit health system caters to communities across Indiana and Ohio. The renewed collaboration involves the upgrade of 10 facilities, the introduction of Glytec's solutions in Emergency Departments, and the addition of two new hospital sites.
This strategic expansion reinforces Parkview Health's unwavering dedication to enhancing patient safety, improving clinical outcomes, and streamlining clinician workflows. It also ensures preparedness for upcoming CMS electronic clinical quality measures (eCQMs) aimed at reducing severe hypoglycemia and hyperglycemia.
Enhancing Quality of Care Through Strategic Initiatives
A pivotal part of this collaboration is Parkview Health's earlier decision to integrate Glytec's FDA-cleared Glucommander® insulin titration software into their operations. This software has become a core element of a comprehensive platform utilized by over 400 hospitals to manage diabetes and glycemic care efficiently.
Addressing CMS Quality Requirements with Advanced Technology
As CMS mandates the reporting of eCQMs for inpatient glycemic control, hospitals are under increasing pressure to elevate care standards. Glytec's platform, now seamlessly linked with Parkview's EHR, provides essential support to healthcare providers, IT specialists, and leadership by offering:
- Real-time clinical decision-making support for both IV and subcutaneous insulin dosing.
- Automated notifications for blood glucose fluctuations to aid proactive clinician responses.
- Comprehensive analytics to evaluate patient metrics such as duration in range, promptness in achieving targets, and financial implications including CMS eCQM compliance.
According to Patrick Cua, CEO of Glytec, "Our collaboration with Parkview Health highlights our shared objective of fostering safe, standardized, and demonstrable improvements in glycemic management outcomes within inpatient settings. This expansion empowers Parkview to effectively deploy a leading diabetes and glycemic management solution across its healthcare system."
Driving Positive Outcomes via Innovative Technology
Glytec’s technology has been embraced by more than 400 hospitals and is supported by a wealth of clinical evidence and intellectual property totaling over 100 patents and peer-reviewed studies. Major outcomes from its implementation have included:
- A remarkable decrease in severe hypoglycemia incidents, achieving reductions of up to 99.8%.
- A shorter patient length of stay, with fewer readmissions and reduced testing costs.
- An average return on investment ranging from 6 to 8 times.
With the rollout of Glytec’s comprehensive platform, Parkview Health is poised to monitor quality indicators in real-time and assess outcomes across both established and newly launched facilities. The system also equips clinical leaders and quality teams with tools for benchmarking, conducting automated audits, and efficiently handling reporting requirements aligned with CMS standards.
About Glytec
Glytec’s pioneering AI-driven technology platform stands as a trusted resource among over 400 hospitals for collaborative diabetes management and insulin dosing. This advanced approach not only enhances patient outcomes but also shortens hospital stays and curtails readmission rates. Glytec’s flagship solution, Glucommander®—the first-ever FDA-cleared cloud-based insulin management software—effortlessly integrates with electronic health records, delivering sophisticated clinical support, workflow notifications, and in-depth analytics aimed at improving care delivery from hospitals to patients' homes.
About Parkview Health
Parkview Health operates as a community-focused, not-for-profit health system, firmly dedicated to serving residents across Indiana and Ohio. With a robust workforce of over 16,000 employees and a network of 15 hospitals, it offers exceptional care across various specialties, including cardiology, orthopedics, and pediatrics. The organization fosters a mission-driven commitment to enhance community health and wellness, reinvesting its resources to elevate service delivery and invest in advanced technology to benefit all patients.
Frequently Asked Questions
What is the primary aim of the Glytec and Parkview Health partnership?
The partnership aims to enhance diabetes and glycemic management, improving patient safety and clinical outcomes.
What specific technologies does Glytec provide to Parkview Health?
Glytec provides the Glucommander® insulin titration software, integrated with Parkview's EHR system for better diabetes management.
How many facilities are involved in the expanded partnership?
The expanded partnership involves the renewal of 10 existing facilities and newly addition of 2 hospitals.
What outcomes has Glytec demonstrated in hospitals?
Glytec has shown measurable improvements, such as a significant reduction in hypoglycemia events and enhanced return on investment.
What is the mission of Parkview Health?
Parkview Health is focused on improving health outcomes and inspiring wellness in the communities they serve.
About The Author
Contact Riley Hayes privately here. Or send an email with ATTN: Riley Hayes as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
